London: Huma Therapeutics completes latest funding round at US$130m

Huma logo

Huma Therapeutics, a global health technology company, has completed its latest funding round with financing of approximately US$130m. The new investment will be used to expand Huma’s digital platform in the US, Asia and the Middle East. Huma’s modular platform supports digital ‘hospitals at home’ across different disease areas across the England NHS, Wales, Germany…

You must be a HMI Subscriber to view this content.

Subscribe Now »